A recent study in the journal PNAS from the lab of Julie Overbaugh reveals a previously unknown antiviral function of a gene ...

Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a ...

In the 59 patients with successful engraftment, vector gene marking in granulocytes was evident at 3 months after transplantation, with a median granulocyte vector copy number of 0.13 copies per cell ...

In today's hyper-connected world, cyber threats are more sophisticated and frequent than ever - ransomware attacks, data breaches, social engineering scams, and advanced persistent threats targeting ...

Scientists may have discovered the first therapy for Huntington’s disease, a brain disorder that until now has had no effective treatments. Researchers at the University of College London (UCL) ...

An experimental gene therapy has slowed the progression of Huntington’s disease by 75 percent, according to results reported by the biotechnology company uniQure this week. Huntington’s is an ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

The Perfect Channel for Survival Game/Dinosaur Enthusiasts! Follow and Turn on Notifications! This Channel is not "Family Friendly" and these videos are not intended for kids. Millions of Americans ...

While initially believed to enhance drought and oxidative stress tolerance, overexpression of MeFER4 in Arabidopsis led to increased sensitivity to multiple abiotic stresses, including drought, ...

Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...